It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
An analysis by News21 shows that $1.1 billion of the $1.4 billion that the National Institutes of Health spent on marijuana research from 2008 to 2014 went to study abuse and addiction. Only $297 million was spent on its effects on the brain and potential medical benefits for those suffering from conditions like chronic pain. News21 is a Carnegie-Knight national student reporting project based at Arizona State University’s Walter Cronkite School of Journalism.
“We don't have new things to treat for pain,” Dr. Todd Vanderah, chief of pharmacology at the University of Arizona, said. “We're still dealing with narcotics that have been around for thousands of years, and it's led to this issue of people abusing drugs, and the rise of heroin.”
Yet researchers like Vanderah have faced challenges getting federal approval and funding to study marijuana’s potential medical uses for these and many other conditions. “The progress is a little limited because research is done based off of grants that have been harder and harder to get,” Vanderah said.
Although medical and even recreational marijuana use has been increasingly legalized by states, the federal government still classifies marijuana as a Schedule 1 drug — along with heroin and ecstasy — defining it as having potential for abuse and no medical benefits.
The approval process for doing any kind of research on marijuana is lengthy and difficult, with the FDA, Drug Enforcement Agency and National Institute on Drug Abuse all playing a role in allowing an approved researcher access to federal funding and federally-provided marijuana.
...
Fewer than 1,000 NIH-supported research projects studied marijuana for purposes other than abuse or addiction in the last seven years. University-backed researchers and a few larger companies have been able to use their own funding, rather than grants from the NIH, and their own advanced laboratories to study marijuana and cannabinoids — the chemicals found within it — as potential treatments for conditions such as seizures and breast cancer pain.
News21 analyzed federally funded drug research projects from 2008 to 2014 using the NIH’s publicly available database. The $1.1 billion the agency spent to study marijuana abuse and addiction was $200 million more than what the organization spent on research into crystal meth, a highly addictive stimulant that the DEA has called an epidemic.
While NIH spent $297 million on grants for non-abuse research of marijuana, it provided two to four times as much for similar research of opiates and benzodiazepines, including drugs such as Xanax, according to the News21 analysis. Opiates are the narcotics that Vanderah said can cause prescription drug dependency or even heroin abuse.
Marijuana was temporarily designated as Schedule 1, but President Richard Nixon created a commission to do a review of the drug to determine if it should keep the most restrictive scheduling. The commission’s findings from research projects and public polls made up almost 4,000 pages of reports and technical papers published in four volumes in 1972. It concluded that marijuana should not be criminalized, and suggested rescheduling the drug. But Nixon decided otherwise.
One hundred sixty substances have been removed, added or transferred from one schedule to another since the Controlled Substances Act went into effect.
Investigators working with Schedule 1 drugs need an additional level of clearance from the DEA, also created during the Nixon administration to enforce the laws of the Controlled Substances Act and to regulate the use of controlled substances. Wallace, the doctor at UC-San Diego, cited five separate state and federal groups that sent him requests before he received approval for his research on how different doses of marijuana might be used to treat pain.
That change is easier said than done, according to Matthew Barden, a DEA spokesman. “A lot of people in the marijuana debate say to just put it under a different schedule. But in order to do that, the FDA would have to change everything.” Barden said. “So we, the DEA, can’t just put something in Schedule 2. That would be a violation of how things are scheduled.”
Rescheduling can be done by congressional or administrative action. A few bills have been proposed in Congress, but they’ve all died in committee.
The administrative route involves more steps and more agencies. To get the ball rolling, a petition must be filed by an interested outside party or by the secretary of Health and Human Services. The attorney general reviews the petition, then sends it back to HHS to request scientific and medical evaluation by the FDA.
Even when researchers are cleared to do federally funded marijuana research, they must obtain their marijuana from a farm at the University of Mississippi operated under the authority of NIDA. The farm is nestled in the eastern portion of the 640-acre Ole Miss campus, a short distance from the stadium where the Rebels play football.
The heavily secured farm is surrounded by fences, guard towers and vaults. The sprawling 12-acre, marijuana farm, with its growing room, is the only federally sanctioned marijuana grow in the country.
Before researchers can obtain marijuana and start their studies, they need three things: an approved investigational new drug application from the FDA, a letter of approval from NIDA and a Schedule 1 clearance from the DEA.
DEA approval is needed for possessing and transporting the marijuana and researchers must prove they have a secure facility to store and keep track of the marijuana. Once they have both FDA and DEA approval, researchers can contact NIDA to obtain their marijuana.
Limited grant availability to fund those requests means that researchers need the backing and funding of a major university — as Vanderah has with Arizona or Wallace has with UC-San Diego — or business investors. Britain-based GW Pharmaceuticals has turned investor funding into marijuana research advances in the United States. Its British base allows GW to work with marijuana grown in its greenhouse in the United Kingdom.
originally posted by: alienjuggalo
a reply to: greencmp
almost 40 years in the war on drugs and I can make a few phone calls and have any drug i want in 20 minutes.
Maybe its time to admit they lost.
originally posted by: alienjuggalo
a reply to: greencmp
almost 40 years in the war on drugs and I can make a few phone calls and have any drug i want in 20 minutes.
Maybe its time to admit they lost.
originally posted by: Chrisfishenstein
I am sure we could get 100 million signatures in about a day.....If that is the case, let's just legalize it all! Let people make their OWN decisions on what they put in their body instead of paying a "doctor" to do that for us....Just a thought
originally posted by: Krazysh0t
originally posted by: alienjuggalo
a reply to: greencmp
almost 40 years in the war on drugs and I can make a few phone calls and have any drug i want in 20 minutes.
Maybe its time to admit they lost.
The worst is that any teenager has better access to those drugs than most adults would, and part of the whole idea of the war on drugs is to keep them out of the hands of kids. Consequently, if the drugs were to be legalized and sold through dispensaries like is done with alcohol, it would be MUCH tougher for kids to obtain them.
originally posted by: Krazysh0t
originally posted by: Chrisfishenstein
I am sure we could get 100 million signatures in about a day.....If that is the case, let's just legalize it all! Let people make their OWN decisions on what they put in their body instead of paying a "doctor" to do that for us....Just a thought
You'll get no arguments from me on that one. I've been an avid critic of the entire war on drugs for quite some time.
originally posted by: alienjuggalo
a reply to: greencmp
almost 40 years in the war on drugs and I can make a few phone calls and have any drug i want in 20 minutes.
Maybe its time to admit they lost.
originally posted by: Krazysh0t
a reply to: TrappedPrincess
Yea, I've been seriously considering doing this as well. I just need to do my research into which companies look the most promising. Got any suggestions on companies by any chance?
originally posted by: TrappedPrincess
originally posted by: Krazysh0t
a reply to: TrappedPrincess
Yea, I've been seriously considering doing this as well. I just need to do my research into which companies look the most promising. Got any suggestions on companies by any chance?
GW pharmaceuticals is the only one I have seen on multiple lists but it is already above $100 a share and is an established company. So the beginning investor isn't going to find their fortune their unless they invest BIG time but it is still not bad as a longterm kind of growth savings account.
Stevia Corp has been referred to as the wild card by one list. Oh I'll just post the link I have and that is a good place to start.
Hot pot stocks to watch